Interestingly, high ER-α expression in serous ovarian cancer is associated with longer OS [47] whereas the role of GPER/GPR30 in ovarian cancer patient survival is being discussed controversially [48,49,50]. Here, GPER1 is linked to ovarian serous adenocarcinoma.